Free Trial

Phreesia (PHR) Stock Price, News & Analysis

Phreesia logo
$29.78 +1.02 (+3.53%)
Closing price 08/22/2025 03:59 PM Eastern
Extended Trading
$29.80 +0.02 (+0.06%)
As of 08/22/2025 05:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Phreesia Stock (NYSE:PHR)

Key Stats

Today's Range
$28.68
$29.94
50-Day Range
$25.42
$29.78
52-Week Range
$17.07
$30.53
Volume
733,260 shs
Average Volume
575,196 shs
Market Capitalization
$1.77 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$32.27
Consensus Rating
Buy

Company Overview

Phreesia Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
79th Percentile Overall Score

PHR MarketRank™: 

Phreesia scored higher than 79% of companies evaluated by MarketBeat, and ranked 219th out of 932 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Phreesia has received a consensus rating of Buy. The company's average rating score is 3.09, and is based on 10 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Phreesia has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Phreesia's stock forecast and price target.
  • Earnings Growth

    Earnings for Phreesia are expected to grow in the coming year, from ($1.10) to ($0.38) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Phreesia is -40.24, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Phreesia is -40.24, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Phreesia has a P/B Ratio of 6.53. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Phreesia's valuation and earnings.
  • Percentage of Shares Shorted

    5.16% of the float of Phreesia has been sold short.
  • Short Interest Ratio / Days to Cover

    Phreesia has a short interest ratio ("days to cover") of 5.1.
  • Change versus previous month

    Short interest in Phreesia has recently decreased by 10.22%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Phreesia does not currently pay a dividend.

  • Dividend Growth

    Phreesia does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    5.16% of the float of Phreesia has been sold short.
  • Short Interest Ratio / Days to Cover

    Phreesia has a short interest ratio ("days to cover") of 5.1.
  • Change versus previous month

    Short interest in Phreesia has recently decreased by 10.22%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Phreesia has a news sentiment score of 1.04. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.66 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 8 news articles for Phreesia this week, compared to 7 articles on an average week.
  • Search Interest

    Only 1 people have searched for PHR on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • MarketBeat Follows

    Only 2 people have added Phreesia to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Phreesia insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,513,007.00 in company stock.

  • Percentage Held by Insiders

    Only 5.50% of the stock of Phreesia is held by insiders.

  • Percentage Held by Institutions

    92.10% of the stock of Phreesia is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Phreesia's insider trading history.
Receive PHR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Phreesia and its competitors with MarketBeat's FREE daily newsletter.

PHR Stock News Headlines

Missed the Last 10,000% Surge? Here’s Your Next Chance
Axcelis Technologies went from $2.50 to $180—a staggering 7,100% return. These are the kinds of small-cap breakouts Fierce Analyst aims to catch before they go mainstream. Our research team uses data and trend analysis to uncover high-potential stocks early. And now, you can get free alerts on the next set of breakout candidates—before the crowd rushes in.tc pixel
Why Phreesia Feels Like The Right Bet In Healthcare Tech
See More Headlines

PHR Stock Analysis - Frequently Asked Questions

Phreesia's stock was trading at $25.16 at the beginning of the year. Since then, PHR shares have increased by 18.3% and is now trading at $29.7760.

Phreesia, Inc. (NYSE:PHR) issued its earnings results on Wednesday, May, 28th. The company reported ($0.07) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.13) by $0.06. The firm's revenue was up 14.5% compared to the same quarter last year.
Read the conference call transcript
.

Phreesia (PHR) raised $127 million in an initial public offering on Thursday, July 18th 2019. The company issued 7,800,000 shares at a price of $15.00-$17.62 per share. J.P. Morgan, Wells Fargo Securities, William Blair, Allen & Company and Piper Jaffray acted as the underwriters for the IPO.

Top institutional investors of Phreesia include Greenhouse Funds LLLP (5.59%), Champlain Investment Partners LLC (4.58%), Brown Advisory Inc. (4.17%) and Franklin Resources Inc. (2.56%). Insiders that own company stock include Chaim Indig, Evan Roberts, Randy Rasmussen, Michael Weintraub, Allison C Hoffman, Amy Beth Vanduyn, Balaji Gandhi, Michael J Davidoff, Mark Douglas Smith, Janet Gunzburg, Yvonne Hui, Lisa Egbuonu-Davis, Gillian Munson and David Linetsky.
View institutional ownership trends
.

Shares of PHR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Phreesia investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Advanced Micro Devices (AMD), CrowdStrike (CRWD), Arista Networks (ANET) and Palo Alto Networks (PANW).

Company Calendar

Last Earnings
5/28/2025
Today
8/23/2025
Next Earnings (Estimated)
9/04/2025
Fiscal Year End
1/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MEDICAL INFO SYS
Sub-Industry
Business Services
Current Symbol
NYSE:PHR
CIK
1412408
Employees
2,082
Year Founded
N/A

Price Target and Rating

High Price Target
$35.00
Low Price Target
$28.00
Potential Upside/Downside
+8.4%
Consensus Rating
Buy
Rating Score (0-4)
3.09
Research Coverage
11 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.74)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$58.53 million
Net Margins
-9.83%
Pretax Margin
-9.15%
Return on Equity
-16.23%
Return on Assets
-11.19%

Debt

Debt-to-Equity Ratio
0.02
Current Ratio
1.95
Quick Ratio
1.95

Sales & Book Value

Annual Sales
$419.81 million
Price / Sales
4.22
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$4.56 per share
Price / Book
6.53

Miscellaneous

Outstanding Shares
59,500,000
Free Float
56,231,000
Market Cap
$1.77 billion
Optionable
Optionable
Beta
0.71

Social Links

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NYSE:PHR) was last updated on 8/23/2025 by MarketBeat.com Staff
From Our Partners